Skip to main content
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1979 Mar;31(2):95–105.

The biochemical genetics of the hexosaminidase system in man.

E Beutler
PMCID: PMC1685763  PMID: 377957

Abstract

Tay-Sachs disease and related GM2 ganglioside storage disorders result from the absence of one form of hexosaminidase, HEX A. The persistence of a second major hexosaminidase isozyme, HEX B, does not protect against the lethal accumulation of GM2 ganglioside in the central nervous system. Using immunologic and biochemical techniques, it has been demonstrated that the two major isozymes of hexosaminidase, HEX A and HEX B, share a common subunit, the structure of HEX A being designated (alpha beta)n and the structure of HEX B being designated as (beta2)n. The minor isozyme, HEX S, is an alpha chain homopolymer designated (alpha2)n, and HEX C seems unrelated to the HEX A, B, S system. The structures of other minor isozymes have not been totally resolved, but HEX I1, I2, and P (which may be identical to I2) appear to represent forms of HEX B.

Full text

PDF
97

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach G., Suzuki K. Heterogeneity of human hepatic H-acetyl-beta-D-hexosaminidose. A activity toward natural glycosphingolipid substrates. J Biol Chem. 1975 Feb 25;250(4):1328–1332. [PubMed] [Google Scholar]
  2. Beutler E., Guinto E., Kuhl W. Placental acid hydrolase purification on concanavalin A-sepharose. J Lab Clin Med. 1975 Apr;85(4):672–677. [PubMed] [Google Scholar]
  3. Beutler E., Guinto E., Kuhl W. Variability of -galactosidase A and B in different tissues of man. Am J Hum Genet. 1973 Jan;25(1):42–46. [PMC free article] [PubMed] [Google Scholar]
  4. Beutler E., Kuhl W., Comings D. Hexosaminidase isozyme in type O Gm2 gangliosidosis (Sandhoff-Jatzkewitz disease). Am J Hum Genet. 1975 Sep;27(5):628–638. [PMC free article] [PubMed] [Google Scholar]
  5. Beutler E., Kuhl W. Subunit structure of human hexosaminidase verified: interconvertibility of hexosaminidase isozymes. Nature. 1975 Nov 20;258(5532):262–264. doi: 10.1038/258262a0. [DOI] [PubMed] [Google Scholar]
  6. Beutler E., Kuhl W. The tissue distribution of hexosaminidase S and hexosaminidase C. Ann Hum Genet. 1977 Oct;41(2):163–167. doi: 10.1111/j.1469-1809.1977.tb01911.x. [DOI] [PubMed] [Google Scholar]
  7. Beutler E., Villacorte D., Kuhl W., Guinto E., Srivastava S. Nonenzymatic conversion of human hexosaminidase A. J Lab Clin Med. 1975 Aug;86(2):195–203. [PubMed] [Google Scholar]
  8. Beutler E., Yoshida A., Kuhl W., Lee J. E. The subunits of human hexosaminidase A. Biochem J. 1976 Dec 1;159(3):541–543. doi: 10.1042/bj1590541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brady R. O. Tay-sachs disease. N Engl J Med. 1969 Nov 27;281(22):1243–1244. doi: 10.1056/NEJM196911272812213. [DOI] [PubMed] [Google Scholar]
  10. Carmody P. J., Rattazzi M. C. Conversion of human hexosaminidase A to hexosaminidase "B" by crude Vibrio cholerae neuraminidase preparations: merthiolate is the active factor. Biochim Biophys Acta. 1974 Nov 5;371(1):117–125. doi: 10.1016/0005-2795(74)90160-3. [DOI] [PubMed] [Google Scholar]
  11. Carroll M., Robinson D. A low-molecular-weight protein cross-reacting with human liver N-acetyl-beta-D-glucosaminidase. Biochem J. 1974 Feb;137(2):217–221. doi: 10.1042/bj1370217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chern J., Beutler E., Kuhl W., Gilbert F., Mellman W. J., Croce C. M. Characterization of heteropolymeric hexosaminidase A in human X mouse hybrid cells. Proc Natl Acad Sci U S A. 1976 Oct;73(10):3637–3640. doi: 10.1073/pnas.73.10.3637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Conzelmann E., Sandhoff K. AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2. Proc Natl Acad Sci U S A. 1978 Aug;75(8):3979–3983. doi: 10.1073/pnas.75.8.3979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Conzelmann E., Sandhoff K., Nehrkorn H., Geiger B., Arnon R. Purification, biochemical and immunological characterisation of hexosaminidase A from variant AB of infantile GM2 gangliosidosis. Eur J Biochem. 1978 Mar;84(1):27–33. doi: 10.1111/j.1432-1033.1978.tb12137.x. [DOI] [PubMed] [Google Scholar]
  15. Dreyfus J. C., Poenaru L., Svennerholm L. Absence of hexosaminidase A and B in a normal adult. N Engl J Med. 1975 Jan 9;292(2):61–63. doi: 10.1056/NEJM197501092920201. [DOI] [PubMed] [Google Scholar]
  16. Egli F., Stalder G. Malformations of kidney and urinary tract in common chromosomal aberrations. I. Clinical studies. Humangenetik. 1973 Mar 23;18(1):1–15. doi: 10.1007/BF00279026. [DOI] [PubMed] [Google Scholar]
  17. Galjaard H., Hoogeveen A., de Wit-Verbeek H. A., Reuser A. J., Keijzer W., Westerveld A., Bootsma D. Tay-Sachs and Sandhoff's disease: intergenic complementation after somatic cell hybridization. Exp Cell Res. 1974 Aug;87(2):444–448. doi: 10.1016/0014-4827(74)90515-1. [DOI] [PubMed] [Google Scholar]
  18. Geiger B., Arnon R. Chemical characterization and subunit structure of human N-acetylhexosaminidases A and B. Biochemistry. 1976 Aug 10;15(16):3484–3493. doi: 10.1021/bi00661a014. [DOI] [PubMed] [Google Scholar]
  19. Geiger B., Calef E., Arnon R. Biochemical and immunochemical characterization of hexosaminidase P. Biochemistry. 1978 May 2;17(9):1713–1717. doi: 10.1021/bi00602a020. [DOI] [PubMed] [Google Scholar]
  20. Gilbert F., Kucherlapati R., Creagan R. P., Murnane M. J., Darlington G. J., Ruddle F. H. Tay-Sachs' and Sandhoff's diseases: the assignment of genes for hexosaminidase A and B to individual human chromosomes. Proc Natl Acad Sci U S A. 1975 Jan;72(1):263–267. doi: 10.1073/pnas.72.1.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Goldstone A., Konecny P., Koenig H. Lysosomal hydrolases: Conversion of acidic to basic forms by neuraminidase. FEBS Lett. 1971 Feb 12;13(1):68–72. doi: 10.1016/0014-5793(71)80667-1. [DOI] [PubMed] [Google Scholar]
  22. Hechtman P., LeBlanc D. Purification and properties of the hexosaminidase A-activating protein from human liver. Biochem J. 1977 Dec 1;167(3):693–701. doi: 10.1042/bj1670693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hoeksema H. L., Reuser A. J., Hoogeveen A., Westerveld A., Braidman I., Robinson D. Characterization of beta-D-N-acetylhexosaminidase isoenzymes in man-Chinese hamster somatic cell hybrids. Am J Hum Genet. 1977 Jan;29(1):14–23. [PMC free article] [PubMed] [Google Scholar]
  24. Hooghwinkel G. J., Veltkamp W. A., Overdijk B., Lisman J. J. Electrophoretic separation of -N-acetylhexosaminidases of human and bovine brain and liver and of Tay-Sachs brain tissue. Hoppe Seylers Z Physiol Chem. 1972 May;353(5):839–841. [PubMed] [Google Scholar]
  25. Hultberg B. N-acetylhexosaminidase activities in Tay-Sachs disease. Lancet. 1969 Nov 29;2(7631):1195–1195. doi: 10.1016/s0140-6736(69)92520-3. [DOI] [PubMed] [Google Scholar]
  26. Ikonne J. U., Ellis R. B. N-acetyl-beta-D-hexosaminidase component A. Different forms in human tissues and fluids. Biochem J. 1973 Nov;135(3):457–462. doi: 10.1042/bj1350457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Jones D. D., Williams G. F., Prochazka B. Source of the pregnancy serum N-acetyl-beta-glucosaminidase isoenzyme during human pregnancy. Enzyme. 1975;20(3):129–137. doi: 10.1159/000458931. [DOI] [PubMed] [Google Scholar]
  28. Kaback M. M., Zeiger R. S., Reynolds L. W., Sonneborn M. Approaches to the control and prevention of Tay-Sachs disease. Prog Med Genet. 1974;10:103–134. [PubMed] [Google Scholar]
  29. Kelly T. E., Reynolds L. W., O'Brien J. S. Segregation within a family of two mutant alleles for hexosaminidase A. Clin Genet. 1976 May;9(5):540–543. doi: 10.1111/j.1399-0004.1976.tb01609.x. [DOI] [PubMed] [Google Scholar]
  30. Lalley P. A., Rattazzi M. C., Shows T. B. Human beta-D-N-acetylhexosaminidases A and B: expression and linkage relationships in somatic cell hybrids. Proc Natl Acad Sci U S A. 1974 Apr;71(4):1569–1573. doi: 10.1073/pnas.71.4.1569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lee J. E., Yoshida A. Purification and chemical characterization of human hexosaminidases A and B. Biochem J. 1976 Dec 1;159(3):535–539. doi: 10.1042/bj1590535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Li Y. T., Mazzotta M. Y., Wan C. C., Orth R., Li S. C. Hydrolysis of Tay-Sachs ganglioside by beta-hexosaminidase A of human liver and urine. J Biol Chem. 1973 Nov 10;248(21):7512–7515. [PubMed] [Google Scholar]
  33. Marinkovic D. V., Marinkovic J. N. Purification of two hexosaminidases from human kidney. Biochem J. 1977 Apr 1;163(1):133–140. doi: 10.1042/bj1630133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Navon R., Geiger B., Yoseph Y. B., Rattazzi M. C. Low levels of beta hexosaminidase A in healthy individuals with apparent deficiency of this enzyme. Am J Hum Genet. 1976 Jul;28(4):339–349. [PMC free article] [PubMed] [Google Scholar]
  35. Navon R., Padeh B., Adam A. Apparent deficiency of hexosaminidase A in healthy members of a family with Tay-Sachs disease. Am J Hum Genet. 1973 May;25(3):287–293. [PMC free article] [PubMed] [Google Scholar]
  36. O'Brien J. S., Okada S., Chen A., Fillerup D. L. Tay-sachs disease. Detection of heterozygotes and homozygotes by serum hexosaminidase assay. N Engl J Med. 1970 Jul 2;283(1):15–20. doi: 10.1056/NEJM197007022830104. [DOI] [PubMed] [Google Scholar]
  37. O'Brien J. S. Suggestions for a nomenclature for the GM2 gangliosidoses making certain (possibly unwarrantable) assumptions. Am J Hum Genet. 1978 Nov;30(6):672–675. [PubMed] [Google Scholar]
  38. Okada S., McCrea M., O'Brien J. S. Sandhoff's disease (GM 2 gangliosidosis type 2): clinical, chemical, and enzyme studies in five patients. Pediatr Res. 1972 Jul;6(7):606–615. [PubMed] [Google Scholar]
  39. Okada S., O'Brien J. S. Tay-Sachs disease: generalized absence of a beta-D-N-acetylhexosaminidase component. Science. 1969 Aug 15;165(3894):698–700. doi: 10.1126/science.165.3894.698. [DOI] [PubMed] [Google Scholar]
  40. Okada S., Veath M. L., O'Brien J. S. Juvenile GM2 gangliosidosis: partial deficiency of hexosaminidase A. J Pediatr. 1970 Dec;77(6):1063–1065. doi: 10.1016/s0022-3476(70)80096-8. [DOI] [PubMed] [Google Scholar]
  41. Price R. G., Dance N. The demonstration of multiple heat stable forms of N-acetyl- -glucosaminidase in normal human serum. Biochim Biophys Acta. 1972 Jun 22;271(1):145–153. doi: 10.1016/0005-2795(72)90142-0. [DOI] [PubMed] [Google Scholar]
  42. Rapin I., Suzuki K., Suzuki K., Valsamis M. P. Adult (chronic) GM2 gangliosidosis. Atypical spinocerebellar degeneration in a Jewish sibship. Arch Neurol. 1976 Feb;33(2):120–130. doi: 10.1001/archneur.1976.00500020048008. [DOI] [PubMed] [Google Scholar]
  43. Rattazzi M. C., Brown J. A., Davidson R. G., Shows T. B. Studies on complementation of beta hexosaminidase deficiency in human GM2 gangliosidosis. Am J Hum Genet. 1976 Mar;28(2):143–154. [PMC free article] [PubMed] [Google Scholar]
  44. Rattazzi M. C., Brown J. A., Davidson R. G., Shows T. B. Tay-Sachs and Sandhoff-Jatzkewitz diseases: complementation of hexosaminidase A deficiency by somatic cell hybridization. Birth Defects Orig Artic Ser. 1975;11(3):232–235. [PubMed] [Google Scholar]
  45. Reuser A. J., Galjaard H. Characterization of beta-D-N-acetylhexosaminidases C and S in fibroplasts from control individuals and patients with Tay-Sachs disease. FEBS Lett. 1976 Nov 15;72(1):1–5. doi: 10.1016/0014-5793(76)80884-8. [DOI] [PubMed] [Google Scholar]
  46. Robinson D., Carroll M. Tay-Sachs disease: interrelation of hexosaminidases A and B. Lancet. 1972 Feb 5;1(7745):322–323. doi: 10.1016/s0140-6736(72)90332-7. [DOI] [PubMed] [Google Scholar]
  47. Robinson D., Stirling J. L. N-Acetyl-beta-glucosaminidases in human spleen. Biochem J. 1968 Apr;107(3):321–327. doi: 10.1042/bj1070321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Ropers H. H., Schwantes U. On the molecular basis of Sandhoff's disease. Humangenetik. 1973;20(2):167–170. doi: 10.1007/BF00284854. [DOI] [PubMed] [Google Scholar]
  49. Sandhoff K., Andreae U., Jatzkewitz H. Deficient hexozaminidase activity in an exceptional case of Tay-Sachs disease with additional storage of kidney globoside in visceral organs. Life Sci. 1968 Mar 15;7(6):283–288. doi: 10.1016/0024-3205(68)90024-6. [DOI] [PubMed] [Google Scholar]
  50. Sandhoff K., Harzer K., Wässle W., Jatzkewitz H. Enzyme alterations and lipid storage in three variants of Tay-Sachs disease. J Neurochem. 1971 Dec;18(12):2469–2489. doi: 10.1111/j.1471-4159.1971.tb00204.x. [DOI] [PubMed] [Google Scholar]
  51. Sandhoff K. Variation of beta-N-acetylhexosaminidase-pattern in Tay-Sachs disease. FEBS Lett. 1969 Aug;4(4):351–354. doi: 10.1016/0014-5793(69)80274-7. [DOI] [PubMed] [Google Scholar]
  52. Srivastava S. K., Ansari N. H. Altered alpha subunits in Tay-Sachs disease. Nature. 1978 May 18;273(5659):245–246. doi: 10.1038/273245a0. [DOI] [PubMed] [Google Scholar]
  53. Srivastava S. K., Beutler E. Antibody against purified human hexosaminidase B cross-reacting with human hexosaminidase A. Biochem Biophys Res Commun. 1972 May 26;47(4):753–759. doi: 10.1016/0006-291x(72)90556-6. [DOI] [PubMed] [Google Scholar]
  54. Srivastava S. K., Beutler E. Hexosaminidase-A and hexosaminidase-B: studies in Tay-Sachs' and Sandhoff's disease. Nature. 1973 Feb 16;241(5390):463–463. doi: 10.1038/241463a0. [DOI] [PubMed] [Google Scholar]
  55. Srivastava S. K., Beutler E. Studies on human beta-D-N-acetylhexosaminidases. 3. Biochemical genetics of Tay-Sachs and Sandhoff's diseases. J Biol Chem. 1974 Apr 10;249(7):2054–2057. [PubMed] [Google Scholar]
  56. Srivastava S. K., Yoshida A., Awasthi Y. C., Beutler E. Studies on human beta-D-N-acetylhexosaminidases. II. Kinetic and structural properties. J Biol Chem. 1974 Apr 10;249(7):2049–2053. [PubMed] [Google Scholar]
  57. Stirling J. L. Separation and characterisation of N-acetyl- -glucosaminidases A and P from maternal serum. Biochim Biophys Acta. 1972 Jun 22;271(1):154–162. doi: 10.1016/0005-2795(72)90143-2. [DOI] [PubMed] [Google Scholar]
  58. Suzuki Y., Suzuki K. Partial deficiency of hexosaminidase component a in juvenile gm2-gangliosidosis. Neurology. 1970 Sep;20(9):848–851. doi: 10.1212/wnl.20.9.848. [DOI] [PubMed] [Google Scholar]
  59. Swallow D. M., Evans L., Saha N., Harris H. Characterization and tissue distribution of N-acetyl hexosaminidase C: suggestive evidence for a separate hexosaminidase locus. Ann Hum Genet. 1976 Jul;40(1):55–66. doi: 10.1111/j.1469-1809.1976.tb00164.x. [DOI] [PubMed] [Google Scholar]
  60. Swallow D. M., Stokes D. C., Corney G., Harris H. Differences between the N-acetyl hexosaminidase isozymes in serum and tissues. Ann Hum Genet. 1974 Jan;37(3):287–302. doi: 10.1111/j.1469-1809.1974.tb01836.x. [DOI] [PubMed] [Google Scholar]
  61. Tallman J. F., Brady R. O., Navon R., Padeh B. Ganglioside catabolism in hexosaminidase A-deficient adults. Nature. 1974 Nov 15;252(5480):254–255. doi: 10.1038/252254a0. [DOI] [PubMed] [Google Scholar]
  62. Tallman J. F., Brady R. O., Quirk J. M., Villalba M., Gal A. E. Isolation and relationship of human hexosaminidases. J Biol Chem. 1974 Jun 10;249(11):3489–3499. [PubMed] [Google Scholar]
  63. Thomas G. H., Taylor H. A., Miller C. S., Axelman J., Migeon B. R. Genetic complementation after fusion of Tay-Sachs and Sandhoff cells. Nature. 1974 Aug 16;250(467):580–582. doi: 10.1038/250580a0. [DOI] [PubMed] [Google Scholar]
  64. Vidgoff J., Buist N. R., O'Brien J. S. Absence of -N-acetyl-D-hexosaminidase A activity in a healthy woman. Am J Hum Genet. 1973 Jul;25(4):372–381. [PMC free article] [PubMed] [Google Scholar]
  65. Wenger D. A., Okada S., O'Brien J. S. Studies on the substrate specificity of hexosaminidase A and B from liver. Arch Biochem Biophys. 1972 Nov;153(1):116–129. doi: 10.1016/0003-9861(72)90427-4. [DOI] [PubMed] [Google Scholar]
  66. Wiktorowicz J. E., Awasthi Y. C., Kurosky A., Srivastava S. K. Purification and properties of human kidney-cortex hexosaminidases A and B. Biochem J. 1977 Jul 1;165(1):49–53. doi: 10.1042/bj1650049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Young E. P., Ellis R. B., Lake B. D., Patrick A. D. Tay-sachs disease and related disorders: Fractionation of brain N-acetyl-beta-hexosaminidase on DEAE-cellulose. FEBS Lett. 1970 Jul 15;9(1):1–4. doi: 10.1016/0014-5793(70)80295-2. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES